dc.creatorSantos, Rafael Ribeiro
dc.creatorCampos, Carli Salviana Maria de
dc.creatorFerretjans, Rodrigo
dc.creatorCarvalho, Andrea Teixeira de
dc.creatorMartins Filho, Olindo Assis
dc.creatorTeixeira, Antonio Lucio
dc.creatorSalgado, João Vinicius
dc.date2020-02-03T13:48:42Z
dc.date2020-02-03T13:48:42Z
dc.date2019
dc.date.accessioned2023-09-26T20:07:16Z
dc.date.available2023-09-26T20:07:16Z
dc.identifierSANTOS, Rafael Ribeiro et al. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment. Nordic Journal of Psychiatry, v. 18, p. 1-7, 2019.
dc.identifier0803-9488
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/39673
dc.identifier10.1080/08039488.2019.1688389
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8848963
dc.descriptionAims: Recent findings suggest that cognitive impairment can be associated with inflammation and immune changes in schizophrenia. We aimed to study possible associations between cytokine levels and cognitive performance in a sample of patients with schizophrenia.Methods: Cognition was assessed with the brief assessment of cognition in schizophrenia in 63 clinically stable outpatients with schizophrenia. Blood was collected and cytokines (IL-2, IL-4, IL-6, IL-10, IL-17A, TNF-α, IFN-γ) were measured by cytometric bead array method. Psychopathological scales were also applied.Results: IL-6 correlated negatively with general cognitive performance (rho = -0.395, p = .017) and positively with antipsychotic dose (rho = 0.412, p = .004). Multiple regression analysis showed that cognitive performance is associated with age and antipsychotic dose (p = .000 and p = .033).Conclusion: The association between IL-6 levels and cognitive performance is dependent on age and antipsychotic dose.
dc.description2040-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherInforma Healthcare
dc.rightsrestricted access
dc.subjectIL-6
dc.subjectSchizophrenia
dc.subjectCognition
dc.subjectInflammation
dc.titleThe association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment
dc.typeArticle


Este ítem pertenece a la siguiente institución